FDA approves Evolence as facial dermal filler
Evolence, a collagen-based dermal filler from OrthoNeutrogena, has been approved by the FDA for the correction of moderate-to-deep facial wrinkles and folds. Evolence uses porcine collagen and results are expected to last ≥6 months.
Evolence is expected to be available in the second half of 2008.
For more information call (800) EVOLENCE or visit www.evolence.com.